OKUR · OnKure Therapeutics, Inc. · Earnings Call Transcripts & Audio
$3.10
-0.17 (-5.20%)
At close · Sep 11
Going-concern doubt
— cleared Aug 4, 2026
The latest filing states the doubt was alleviated.
“As of December 31, 2025, the Company had determined that substantial doubt about the Company's ability to continue as a going concern for a period of at least 12 months from the date of the issuance of those financial statements did exist. However, following completion of the 2026 Private Placement (see Note 9), management believes the Company's cash, cash equivalents and marketable securities will be sufficient to fund its current operating plan for at least the next 12 months from the date of issuance of these condensed consolidated financial statements and as such substantial doubt has been alleviated.”View the 10-Q filed Aug 4, 2026
Market Cap
$125.54M
Shares
40.50M
OnKure Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for OnKure Therapeutics, Inc. (OKUR), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Earnings call
FY25 · Q2
2025-08-12
OnKure Therapeutics, Inc. (OKUR) Q2 2025 Earnings Call
Diluted EPS
$-1.14
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-04-08
OnKure Therapeutics, Inc. (OKUR) Q4 2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–2 of 2 earnings calls
Key facts
CIK
1637715
CUSIP
68277Q105
13F (30d)
40 filings
40 filers
Visit website
Investor relations